| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000267249.1 |
Motesanib |
Breast invasive carcinoma |
0.018146487 |
Resistant |
| ENSG00000267249.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.010750936 |
Resistant |
| ENSG00000267249.1 |
Motesanib |
Stomach adenocarcinoma |
0.042423351 |
Resistant |